Riga Thomas J 4
4 · SPECTRUM PHARMACEUTICALS INC · Filed Jan 5, 2023
Insider Transaction Report
Form 4
Riga Thomas J
Chief Operating Officer
Transactions
- Sale
Common Stock, $0.001 par value
2023-01-03$0.38/sh−23,929$9,141→ 1,189,411 total - Award
Common Stock, $0.001 par value
2023-01-03+888,000→ 2,077,411 total - Award
Stock Option (Right to Buy)
2023-01-03+3,112,000→ 3,112,000 totalExercise: $0.38Exp: 2033-01-03→ Common Stock (3,112,000 underlying)
Holdings
- 14,139(indirect: By 401(k))
Common Stock, $0.001 par value
Footnotes (3)
- [F1]All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.
- [F2]One third of the aggregate amount of restricted stock units shall vest on each of January 3, 2024, 2025 and 2026, respectively.
- [F3]One third of the aggregate amount of option shares shall vest on each of January 3, 2024, 2025 and 2026, respectively.